Navigation Links
Placebo for relief from emotions

Researchers have shown that placebo treatment can reduce the nature of emotional experience// the patients can have from uncommon experiences.

Placebo treatment consists of dummy medication or intervention. This can be in the form of harmless tablets, saline water injections etc.

In the new research done by the scientists of Karolinska Institute, researchers have shown that placebo treatment can effectively control the impact of negative experiences by controlling the expression of emotions generated through the exposure. Research shows that the placebo treatment affects the neural circuitry of the brain in case of relieving anxiety in the same way as it does for pain. The placebo treatment, from previous studies, had been known to relieve pain in at least 35% of the cases where it is administered.

In the new study, researchers had used functional magnetic resonance imaging (fMRI) to measure the blood flow in the brain in order to maintain brain activity. The results of the study showed that subjects reduced ratings of unpleasantness by about 29%. This reduction in rating unpleasant experiences as seen by subjects in photographs correlated with the fMRI scan reports that showed reduced activity in the seats of emotions in the brain with the placebo treatment.

Reference: Neuron, June 2005
'"/>




Page: 1

Related medicine news :

1. Mystery Of The Placebo Effect, Yet To Be Solved
2. Placing a Finger on Responses to Placebo Types
3. Study Shows No Difference between Policosanol and Placebo
4. Codeine As Useful As A Placebo
5. Common PTSD Drug is No More Effective Than Placebo
6. George Bush pledges 200 million dollars for AIDS relief
7. Acupuncture superseeds massage therapy for short term relief of pain
8. Acupuncture provides relief
9. Acupuncture to bring relief to patients with dry mouth
10. Finding relief from Excruciating Headaches a challenge
11. Exercising for long term relief from lower back pain
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Placebo for relief from emotions

(Date:7/18/2008)...state-of-the-art radiation technology ...ER, Texas, July 18 /PRNewswire/ -- Patients of Tri...as Oncology-Tyler are among the first,in the natio...ipment that,provides faster and more accurate trea...p://www.newscom.com/cgi-bin/prnh/20061117/DAF023LO...
(Date:7/18/2008)...the University of Pennsylvania School of Medicine ...ed with familial Alzheimer,s disease disrupt the f...ns, called PS1 and PS2 (presenilin 1 and 2), inter...ular cell compartment. , "The ,calcium dysregula...al Alzheimer,s disease has been suggested by previ...
(Date:7/18/2008)...istance to chemotherapy drugs, sometimes abruptly,...ing well to reduce tumors or hold them in check? ...lt when this occurs is all too familiar: patients ...ecome resistant. , A team of researchers at Cold...stand the genetic underpinnings of cancer therapy ...
(Date:7/18/2008)...wswire-USNewswire/ -- William S.,Harris, Ph.D., FA...ter,dated July 16:, Eating fish, especially oily...heart disease prevention. Fish is low in total and...ce minerals, and contains,long-chain omega-3 fatty...thy omega-3s include salmon, trout, albacore tuna,...
Breaking Medicine News(10 mins):Health News:Video: Trinity Mother Frances and Texas Oncology-Tyler Among the First in U.S. to Boast New Cancer-Fighting Technology 2Health News:Video: Trinity Mother Frances and Texas Oncology-Tyler Among the First in U.S. to Boast New Cancer-Fighting Technology 3Health News:Video: Trinity Mother Frances and Texas Oncology-Tyler Among the First in U.S. to Boast New Cancer-Fighting Technology 4Health News:Video: Trinity Mother Frances and Texas Oncology-Tyler Among the First in U.S. to Boast New Cancer-Fighting Technology 5Health News:Calcium may be the key to understanding Alzheimer's disease 2Health News:Calcium may be the key to understanding Alzheimer's disease 3Health News:CSHL scientists correlate enzyme expression levels with chemotherapy drug response 2Health News:CSHL scientists correlate enzyme expression levels with chemotherapy drug response 3Health News:CSHL scientists correlate enzyme expression levels with chemotherapy drug response 4Health News:An Open Letter Regarding Recent Reports That Low-Fat Fish Like Tilapia Are Unhealthy (July 16, 2008) 2Health News:An Open Letter Regarding Recent Reports That Low-Fat Fish Like Tilapia Are Unhealthy (July 16, 2008) 3
...s who are training for marathon running events may...ia (EAH) that can develop from low levels of sodiu...ened when the athletes drink excess amounts of flu... is increasing, but athletes, coaches, and medical...
...ving 3,189 school children from Denmark, Estonia a...ilies don’t necessarily have worse health compared...ucated parents. The results of the study were publ...the study challenge the results of the earlier rep...
...ear of marriage a wife may be able to control how ...abuse like the use of marijuana. However the rever...ollected showed that in the first year of marriage... likely to start or resume smoking marijuana if th...
...nning a pregnancy take a general multivitamin supp...t thing for them and their baby, however a recent ...development defects in unborn babies but many wome...multivitamin supplements say researchers based on ...
Other Medicine News:Health News:Athletes Warned Of Exercise-Associated Hyponatremia 2Health News:Wife May Determine Husband’s Marijuana Use 2
(Date:7/16/2008)... Raptor to Support Phase 2a Clinical Trial at UCSD...-- Raptor,Pharmaceuticals Corp. ("Raptor" or the "...ced the execution of a collaboration agreement (th...San Diego ("UCSD") to,include a Phase 2a clinical ... cysteamine bitartrate ("Cysteamine") in adolescen...
(Date:7/15/2008)... Fund Completion of Phase III Trials of Light Infu...tatic Colorectal Cancer and Phase I/II a... BELLEVUE, Wash., July 15 /- Light S...pany developing Light Infusion Therapy(TM),(Litx(T...nounced that it,has raised $40.1 million in a Seri...
(Date:7/15/2008)...Reports 92 Percent Response Rate to Combination Tr...ll/ -- Cephalon, Inc. (Nasdaq:,CEPH) announced tod...in the,Journal of Clinical Oncology, 92 percent of... cell non-Hodgkin,s lymphoma (NHL) responded to tr...e) for Injection plus rituximab.,This combination ...
(Date:7/14/2008)... VIEW, Calif., July 14 /- M...nounced it has initiated its,Phase 3 clinical prog...or,migraine., MAP0004 is orally inhaled and self-...oprietary Tempo(R) inhaler. In the company,s prior...ief in as fast as 10 minutes,with relief sustaine...
Breaking Medicine Technology:Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 2Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 3Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 4Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 5Light Sciences Oncology Raises $40.1 Million in Series C Financing 2Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkin's Lymphoma 2Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkin's Lymphoma 3Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkin's Lymphoma 4Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkin's Lymphoma 5MAP Pharmaceuticals Initiates Phase 3 Clinical Trial in Patients With Migraine 2MAP Pharmaceuticals Initiates Phase 3 Clinical Trial in Patients With Migraine 3MAP Pharmaceuticals Initiates Phase 3 Clinical Trial in Patients With Migraine 4Arobella Medical LLC Launches Qoustic Wound Therapy System 28TM 29 3174 1Arobella Medical LLC Launches Qoustic Wound Therapy System 28TM 29 3174 2Arobella Medical LLC Launches Qoustic Wound Therapy System 28TM 29 3174 3AtriCure Announces Initiation of the ABLATE Pivotal Trial to Evaluate the Isolator Synergy 28TM 29 Bipolar Ablation System to Treat Atrial Fibrillatio 3172 1AtriCure Announces Initiation of the ABLATE Pivotal Trial to Evaluate the Isolator Synergy 28TM 29 Bipolar Ablation System to Treat Atrial Fibrillatio 3172 2AtriCure Announces Initiation of the ABLATE Pivotal Trial to Evaluate the Isolator Synergy 28TM 29 Bipolar Ablation System to Treat Atrial Fibrillatio 3172 3AtriCure Announces Initiation of the ABLATE Pivotal Trial to Evaluate the Isolator Synergy 28TM 29 Bipolar Ablation System to Treat Atrial Fibrillatio 3172 4American Chemical Societys Weekly PressPac Feb 6 2008 11486 1American Chemical Societys Weekly PressPac Feb 6 2008 11486 2American Chemical Societys Weekly PressPac Feb 6 2008 11486 3American Chemical Societys Weekly PressPac Feb 6 2008 11486 4American Chemical Societys Weekly PressPac Feb 6 2008 11486 5American Chemical Societys Weekly PressPac Feb 6 2008 11486 6American Chemical Societys Weekly PressPac Feb 6 2008 11486 7American Chemical Societys Weekly PressPac Feb 6 2008 11486 8American Chemical Societys Weekly PressPac Feb 6 2008 11486 9FindCareHomes com Features New Interactive Tools and Free Services to Simplify the Search for Elder Home Care 11484 1FindCareHomes com Features New Interactive Tools and Free Services to Simplify the Search for Elder Home Care 11484 2
...ne 4, 2007 – Data presented,today at this ye...ASCO) meeting in Chicago show that a novel combina...uorouracil (5-FU) therapy UFT,(tegafur–uraci...ponse rate in the first-line treatment of metastat...(Study of CPT-11 with Oxaliplatin combined,with UF...
...ne 4, 2007 – Genta,Incorporated (Nasdaq: GNT...ase 2 clinical trial of its marketed product, Gani...b (Rituxan®;,Genentech/IDEC) and dexamethasone...in’s lymphoma (NHL). The data were,presented...Clinical,Oncology (ASCO) in Chicago, IL. , ,Previo...
Other Medicine Technology:Merck at ASCO 2007: New Data Demonstrate the Value of UFT as an,Important Treatment Option for Patients With Metastatic Colorectal,Cancer 2Merck at ASCO 2007: New Data Demonstrate the Value of UFT as an,Important Treatment Option for Patients With Metastatic Colorectal,Cancer 3Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 2Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 3Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 4Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 5
Micro Decker Pituitary Rongeurs, 6 length 150 mm, heavy duty.
The Skull Pins are inserted into the receptacles of the Skull Clamp and fixate the head during surgery.
It is designed for rigid skeletal fixation, and allows the surgeon greater freedom in positioning the fixation pins. The 3-point rigid skeletal fixation is designed for the supine, prone, lateral, or
...rl Storz borescopes are rigid endoscopes for gener...opkins lens system. The diameters of borescopes, i..., with viewing directions from 0 up to a 120 retro...lens and wide angle view. Endoscopes with working ...
Medicine Products: